X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2806) 2806
Publication (283) 283
Book Review (12) 12
Magazine Article (10) 10
Book Chapter (7) 7
Book / eBook (4) 4
Newspaper Article (4) 4
Government Document (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1727) 1727
animals (1640) 1640
antiprotozoal agents - administration & dosage (1551) 1551
antiprotozoal agents - therapeutic use (1300) 1300
index medicus (1245) 1245
male (1181) 1181
female (1137) 1137
adult (684) 684
antiprotozoal agents - pharmacology (651) 651
mice (590) 590
leishmaniasis, visceral - drug therapy (579) 579
treatment outcome (547) 547
parasitology (511) 511
pharmacology & pharmacy (485) 485
infectious diseases (467) 467
middle aged (445) 445
leishmaniasis (437) 437
leishmaniasis, cutaneous - drug therapy (434) 434
visceral leishmaniasis (433) 433
parasitic diseases (405) 405
tropical medicine (404) 404
microbiology (400) 400
adolescent (367) 367
administration, oral (360) 360
child (325) 325
antiprotozoal agents - adverse effects (323) 323
mice, inbred balb c (309) 309
cutaneous leishmaniasis (276) 276
parasites (275) 275
research (274) 274
immunology (270) 270
care and treatment (264) 264
drug therapy, combination (260) 260
amphotericin b - administration & dosage (251) 251
health aspects (244) 244
drug therapy (234) 234
chemotherapy (226) 226
child, preschool (226) 226
phosphorylcholine - analogs & derivatives (225) 225
research article (225) 225
efficacy (223) 223
meglumine - administration & dosage (221) 221
antiprotozoal agents - chemistry (220) 220
in-vitro (220) 220
infection (219) 219
drugs (216) 216
organometallic compounds - administration & dosage (216) 216
infections (215) 215
disease models, animal (213) 213
kala-azar (211) 211
amphotericin b - therapeutic use (197) 197
young adult (195) 195
antiprotozoal agents - pharmacokinetics (191) 191
meglumine antimoniate (191) 191
miltefosine (189) 189
arctic medicine. tropical medicine (186) 186
diagnosis (186) 186
leishmaniasis - drug therapy (183) 183
amphotericin b (175) 175
meglumine - therapeutic use (173) 173
aged (170) 170
drug resistance (170) 170
leishmania donovani - drug effects (170) 170
organometallic compounds - therapeutic use (170) 170
dose-response relationship, drug (165) 165
leishmania - drug effects (157) 157
veterinary sciences (156) 156
sodium stibogluconate (154) 154
public, environmental & occupational health (153) 153
leishmania (148) 148
leishmaniasis, visceral - parasitology (148) 148
public aspects of medicine (148) 148
analysis (147) 147
medicine (147) 147
parasitic sensitivity tests (146) 146
time factors (146) 146
antiprotozoal agents (139) 139
chemistry, medicinal (138) 138
tropical diseases (137) 137
drug administration schedule (135) 135
leishmaniasis, cutaneous - parasitology (132) 132
dogs (129) 129
infant (129) 129
therapy (129) 129
liposomes (127) 127
donovani (125) 125
rats (125) 125
dosage and administration (124) 124
toxicity (123) 123
phosphorylcholine - administration & dosage (119) 119
india (116) 116
cricetinae (115) 115
phosphorylcholine - therapeutic use (110) 110
vector-borne diseases (110) 110
inhibitory concentration 50 (109) 109
macrophages (109) 109
medicine, general & internal (108) 108
resistance (108) 108
pharmacology (107) 107
follow-up studies (105) 105
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2611) 2611
French (49) 49
German (43) 43
Spanish (43) 43
Russian (20) 20
Portuguese (14) 14
Japanese (12) 12
Italian (9) 9
Turkish (8) 8
Romanian (5) 5
Danish (4) 4
Hebrew (4) 4
Polish (4) 4
Arabic (3) 3
Dutch (3) 3
Norwegian (2) 2
Chinese (1) 1
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Microbiology and Infection, ISSN 1198-743X, 10/2011, Volume 17, Issue 10, pp. 1478 - 1483
Although there have been significant advances in the treatment of visceral leishmaniasis (VL), there remain challenges to ensure that treatments effective in... 
Cutaneous leishmaniasis | standardization | drug sensitivity | HIV co-infection | visceral leishmaniasis | HIV co‐infection | Visceral leishmaniasis | Drug sensitivity | Standardization | INFECTIOUS DISEASES | ORAL MILTEFOSINE | EFFICACY | RANDOMIZED-TRIAL | MICROBIOLOGY | DRUG-RESISTANCE | LIPOSOMAL AMPHOTERICIN-B | INDIAN VISCERAL LEISHMANIASIS | AZAR DERMAL LEISHMANIASIS | IN-VIVO | WORLD CUTANEOUS LEISHMANIASIS | DOUBLE-BLIND | Coinfection - drug therapy | Humans | Research - organization & administration | Coinfection - parasitology | Anti-HIV Agents - administration & dosage | Leishmaniasis, Cutaneous - epidemiology | Anti-HIV Agents - therapeutic use | Leishmaniasis, Visceral - parasitology | Clinical Trials as Topic - standards | Paromomycin - therapeutic use | HIV Infections - virology | Paromomycin - administration & dosage | India - epidemiology | Leishmaniasis, Cutaneous - drug therapy | HIV - pathogenicity | Coinfection - virology | Drug Discovery | Leishmaniasis, Visceral - drug therapy | Leishmaniasis, Cutaneous - parasitology | Antiprotozoal Agents - administration & dosage | HIV Infections - drug therapy | HIV Infections - parasitology | Leishmania - pathogenicity | Antiprotozoal Agents - therapeutic use | Leishmaniasis, Visceral - epidemiology | Chemotherapy | Leishmaniasis | Universities and colleges | HIV (Viruses) | Analysis | Cancer | Research & development--R&D | Parasitic diseases
Journal Article
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 05/2015, Volume 96, pp. 296 - 307
Journal Article
Journal Article
The American Journal of Cardiology, ISSN 0002-9149, 2004, Volume 94, Issue 9, pp. 1140 - 1146
Three-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors (statins) are first-line treatments for hypercholesterolemia. Although exceedingly well... 
CLARITHROMYCIN | INDUCED RHABDOMYOLYSIS | LOVASTATIN | CARDIAC & CARDIOVASCULAR SYSTEMS | CONCOMITANT USE | ERYTHROMYCIN | FATAL RHABDOMYOLYSIS | ITRACONAZOLE | ROSUVASTATIN | DRUG-INTERACTION | CYCLOSPORINE | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Pyrroles - pharmacokinetics | Cytochrome P-450 Enzyme Inhibitors | Cytochrome P-450 Enzyme System - administration & dosage | Area Under Curve | Heptanoic Acids - pharmacokinetics | Humans | Middle Aged | Mibefradil - pharmacokinetics | Male | Protein Synthesis Inhibitors - administration & dosage | Verapamil - administration & dosage | Dose-Response Relationship, Drug | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacokinetics | Antiprotozoal Agents - pharmacokinetics | Drug Interactions | Itraconazole - pharmacokinetics | Pyrroles - administration & dosage | Clarithromycin - pharmacokinetics | Mibefradil - administration & dosage | Clarithromycin - administration & dosage | Heptanoic Acids - administration & dosage | Adult | Female | Itraconazole - administration & dosage | Drug Therapy, Combination | Double-Blind Method | Simvastatin - administration & dosage | Verapamil - pharmacokinetics | Biomarkers - blood | Simvastatin - pharmacokinetics | Protein Synthesis Inhibitors - pharmacokinetics | Atorvastatin Calcium | Anticholesteremic Agents - pharmacokinetics | Pravastatin - administration & dosage | Anticholesteremic Agents - administration & dosage | Adolescent | Antiprotozoal Agents - administration & dosage | Calcium Channel Blockers - administration & dosage | Creatine Kinase - drug effects | Calcium Channel Blockers - pharmacokinetics | Pravastatin - pharmacokinetics
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9764, pp. 477 - 486
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 06/2011, Volume 5, Issue 6, p. e1151
Journal Article